Published in Qual Life Res on January 01, 1997
Loneliness and HIV-related stigma explain depression among older HIV-positive adults. AIDS Care (2010) 1.78
Strategies to improve retention in randomised trials. Cochrane Database Syst Rev (2013) 1.58
Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008. Qual Life Res (2010) 1.56
Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol (2013) 0.97
Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes (2003) 0.96
Comparison of the self-administered and interviewer-administered modes of the child-OIDP. Health Qual Life Outcomes (2008) 0.93
Interviewer versus self-administered health-related quality of life questionnaires - does it matter? Health Qual Life Outcomes (2011) 0.92
The Relationship between Visual Impairment and Health-Related Quality of Life in Korean Adults: The Korea National Health and Nutrition Examination Survey (2008-2012). PLoS One (2015) 0.84
Effects of mode of administration (MOA) on the measurement properties of the EORTC QLQ-C30: a randomized study. Health Qual Life Outcomes (2010) 0.82
Telephone consultation for improving health of people living with or at risk of HIV: a systematic review. PLoS One (2012) 0.75
An equivalence study: Are patient-completed and telephone interview equivalent modes of administration for the EuroQol survey? Health Qual Life Outcomes (2017) 0.75
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother (1986) 4.51
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
Condoms prevent transmission of AIDS-associated retrovirus. JAMA (1986) 3.78
A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med (1992) 3.65
Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science (1999) 3.30
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res (1997) 3.16
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res (2008) 2.81
Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA (1996) 2.70
Identification and characterization of a family of Rab11-interacting proteins. J Biol Chem (2001) 2.64
The American Stop Smoking Intervention Study. Conceptual framework and evaluation design. Eval Rev (1999) 2.57
Staphylococcus aureus meningitis: review of 28 cases. Rev Infect Dis (1989) 2.51
Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest (1999) 2.48
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health (2006) 2.35
Review of duodenal diverticula. Am J Gastroenterol (1991) 2.33
Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A (2001) 2.32
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29
Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J Infect Dis (1998) 2.07
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
A factor analysis of the Klein sexual orientation grid in two disparate samples. Arch Sex Behav (1993) 1.98
Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med (1999) 1.96
Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood (1990) 1.93
The ventilatory effects of auto-positive end-expiratory pressure development during cardiopulmonary resuscitation. Crit Care Med (1999) 1.90
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
SF-36 summary scores: are physical and mental health truly distinct? Med Care (1998) 1.83
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Pleiotropic changes controlled by the pre-T-cell receptor. Curr Opin Immunol (1999) 1.71
The relation between heat produced and phosphorylcreatine split during isometric contraction of frog's muscle. J Physiol (1967) 1.71
Stability assessment of distal radius fractures. Injury (1989) 1.67
Clinical and pathological findings of a newly recognized disease of elephants caused by endotheliotropic herpesviruses. J Wildl Dis (2000) 1.66
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Ann Intern Med (1990) 1.65
Factors associated with stress among emergency medicine residents. Ann Emerg Med (1989) 1.63
Rapid detection of microbial contamination in frozen vegetables by automated impedance measurements. Appl Environ Microbiol (1977) 1.63
Pneumocystis carinii pneumonia: a clinical review. Am Fam Physician (1999) 1.61
Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res (2002) 1.60
Relationship between body mass indices and measures of body adiposity. Am J Public Health (1986) 1.57
Motor cortical representation of the pelvic floor muscles. J Urol (2011) 1.56
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A (1993) 1.54
Asymptomatic blood donor with a false positive HTLV-III Western blot. N Engl J Med (1986) 1.54
HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus. J Biol Chem (2001) 1.53
HIV-specific cellular and humoral immune responses in primary HIV infection. AIDS Res Hum Retroviruses (1996) 1.51
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS (1993) 1.48
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS (2000) 1.48
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A (1996) 1.44
Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retroviruses (1995) 1.42
Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav (2013) 1.41
Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. Am J Med (1991) 1.41
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis (1994) 1.40
Predictors of optimal virological response to potent antiretroviral therapy. AIDS (1999) 1.40
Safe paediatric neurosurgery 2001. Br J Neurosurg (2002) 1.40
Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. J Infect Dis (1991) 1.37
Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet (1988) 1.36
Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects. Clin Pharmacol Ther (1995) 1.34
Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy. J Infect Dis (1999) 1.32
Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J Infect Dis (2001) 1.32
Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Arch Ophthalmol (1986) 1.31
Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1993) 1.31
A study of occupational stress and depression among emergency physicians. Ann Emerg Med (1992) 1.28
Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy. AIDS Res Hum Retroviruses (2006) 1.26
Predictors of work satisfaction among SHOs during accident and emergency medicine training. Arch Emerg Med (1993) 1.24
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther (2011) 1.22
Precision neutron interferometric measurement of the nd coherent neutron scattering length and consequences for models of three-nucleon forces. Phys Rev Lett (2003) 1.21
Phase-conjugating mirror with continuous-wave gain. Opt Lett (1980) 1.21
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy. J Infect Dis (1998) 1.20
Prototype trial design for rapid dose selection of antiretroviral drugs: an example using emtricitabine (Coviracil). J Antimicrob Chemother (2001) 1.20
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Ann Intern Med (2000) 1.20
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med (1991) 1.20
Crucial function of the pre-T-cell receptor (TCR) in TCR beta selection, TCR beta allelic exclusion and alpha beta versus gamma delta lineage commitment. Immunol Rev (1998) 1.19
The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha/beta T cell development. J Exp Med (1999) 1.19
Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol (2002) 1.19
On the role of the pre-T cell receptor in alphabeta versus gammadelta T lineage commitment. Immunity (1998) 1.19
Malignancy in a vestibular schwannoma. Report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature. Br J Neurosurg (2002) 1.17
Expression of lactose permease in contiguous fragments as a probe for membrane-spanning domains. Biochemistry (1994) 1.15
Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children. HIV Med (2011) 1.14
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
Insertional mutagenesis of hydrophilic domains in the lactose permease of Escherichia coli. Proc Natl Acad Sci U S A (1992) 1.13
Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.13
Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. J Infect Dis (1994) 1.13
From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. J Infect Dis (1991) 1.13
Refractory mucosal candidiasis in advanced human immunodeficiency virus infection. Clin Infect Dis (2000) 1.12
Safety and pharmacokinetics of once-daily regimens of soft-gel capsule saquinavir plus minidose ritonavir in human immunodeficiency virus-negative adults. Antimicrob Agents Chemother (2000) 1.12
Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis (2001) 1.11